Prothena | DEBITO





DEBITO Cambiamento Data
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Agios Pharmaceuticals USD 48.76M 47.62M 2025-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
ALKERMES USD 72.68M 293.32M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 1.7M 2025-12
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Exelixis USD 176.46M 3.38M 2025-09
Immunic USD 0 0 2024-06
Incyte USD 41.27M 1.14M 2025-09
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
MacroGenics USD 37.01M 238K 2025-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Prothena USD 9.08M 699K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06
Xoma USD 120.79M 3.27M 2024-06


Prothena DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.